# Cumberland Pharmaceuticals Inc: Form DEF 14A, filed Mar 16, 2022

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: DEF 14A
- Filed: 2022-03-16
- Accepted by EDGAR: Mar 16, 2022, 17:09 ET
- Period: 2022-04-28
- Accession: 0001628280-22-006406
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000162828022006406/a2022proxystatement.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000162828022006406/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000162828022006406/a2022proxystatement.htm

Filed Mar 16, 2022.
Source: SEC EDGAR, the filing index for accession 0001628280-22-006406. Last ingested by Listed: Oct 26, 2026, 16:41 ET. No prices; not investment advice.